Arkadios Wealth Advisors

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1800798 ATLANTA, GA

Position in VRTX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,654,110

+$9,058 QoQ

Shares Held

3,330

-9.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#720

of 1,735 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Arkadios Wealth Advisors holds $12,683,379 across 13 Biotechnology names. VRTX ranks #3 (13.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	5,205	$3,245,525
2	JAZZ	Jazz Pharmaceuticals plc	9,439	$2,274,514
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	3,330	$1,654,110
4	HALO	Halozyme Therapeutics, Inc.	20,646	$1,615,961
5	TYRA	Tyra Biosciences, Inc.	49,336	$1,575,791
6	MRNA	Moderna, Inc.	15,033	$1,052,760
7	CRSP	CRISPR Therapeutics AG	10,487	$571,960
8	ROIV	Roivant Sciences Ltd.	8,866	$313,767

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,654,110	3,330	-9.6%	Shares	Sole	2026-08-10
2026-03-31	$1,645,052	3,684	-7.1%	Shares	Sole	2026-05-18
2025-12-31	$1,797,571	3,965	+69.9%	Shares	Sole	2026-02-13
2025-09-30	$914,086	2,334	+8.5%	Shares	Sole	2025-10-29
2025-06-30	$958,069	2,152	+47.9%	Shares	Sole	2025-08-04
2025-03-31	$705,412	1,455	+34.6%	Shares	Sole	2025-05-08
2024-12-31	$435,318	1,081	+61.1%	Shares	Sole	2025-01-15
2024-09-30	$312,068	671	+454.5%	Shares	Sole	2024-10-24
2021-09-30	$21,948	121	+21.0%	Shares	Sole	2021-10-19
2021-06-30	$20,163	100	+2400.0%	Shares	Sole	2021-07-28
2020-03-31	$951	4	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.